{"id":"https://openalex.org/W4403533442","doi":"https://doi.org/10.1136/rmdopen-2024-004514","title":"Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47","display_name":"Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403533442","doi":"https://doi.org/10.1136/rmdopen-2024-004514","pmid":"https://pubmed.ncbi.nlm.nih.gov/39424404","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11492937"},"language":"en","primary_location":{"id":"doi:10.1136/rmdopen-2024-004514","doi":"https://doi.org/10.1136/rmdopen-2024-004514","is_oa":true,"landing_page_url":"https://doi.org/10.1136/rmdopen-2024-004514","pdf_url":"https://rmdopen.bmj.com/content/10/4/e004514.full.pdf","source":{"id":"https://openalex.org/S2738706341","display_name":"RMD Open","issn_l":"2056-5933","issn":["2056-5933"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://rmdopen.bmj.com/content/10/4/e004514.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090753435","display_name":"Josef S Smolen","orcid":"https://orcid.org/0000-0002-4302-8877","observed_orcids":["https://orcid.org/0000-0002-4302-8877"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Josef S Smolen","raw_affiliation_strings":["Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria","Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria josef.smolen@meduniwien.ac.at"],"raw_orcid":"https://orcid.org/0000-0002-4302-8877","affiliations":[{"raw_affiliation_string":"Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria josef.smolen@meduniwien.ac.at","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014313027","display_name":"Jakub Trefler","orcid":"https://orcid.org/0009-0003-3912-3518","observed_orcids":["https://orcid.org/0009-0003-3912-3518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jakub Trefler","raw_affiliation_strings":["REUMA RESEARCH, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"REUMA RESEARCH, Warsaw, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080655694","display_name":"Artur J. Racewicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Artur Racewicz","raw_affiliation_strings":["Zdrowie Osteo-Medic, Bia\u0142ystok, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zdrowie Osteo-Medic, Bia\u0142ystok, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023958759","display_name":"Janusz Jaworski","orcid":"https://orcid.org/0000-0002-2664-1012","observed_orcids":["https://orcid.org/0000-0002-2664-1012"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janusz Jaworski","raw_affiliation_strings":["Klinika Reuma Park, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinika Reuma Park, Warsaw, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058833374","display_name":"Agnieszka E. Zielinska","orcid":"https://orcid.org/0000-0001-7630-1123","observed_orcids":["https://orcid.org/0000-0001-7630-1123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agnieszka Zieli\u0144ska","raw_affiliation_strings":["MICS Centrum Medyczne, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MICS Centrum Medyczne, Warsaw, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063674909","display_name":"Marek Krogulec","orcid":"https://orcid.org/0000-0002-5698-9706","observed_orcids":["https://orcid.org/0000-0002-5698-9706"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marek Krogulec","raw_affiliation_strings":["NZOZ Lecznica Mak-Med, Nadarzyn, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NZOZ Lecznica Mak-Med, Nadarzyn, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032940273","display_name":"S\u0142awomir Jeka","orcid":"https://orcid.org/0000-0003-2766-8046","observed_orcids":["https://orcid.org/0000-0003-2766-8046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S\u0142awomir Jeka","raw_affiliation_strings":["MICS Centrum Medyczne Toru\u0144, Toru\u0144, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MICS Centrum Medyczne Toru\u0144, Toru\u0144, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032246259","display_name":"Rafa\u0142 Wojciechowski","orcid":"https://orcid.org/0009-0005-1132-3993","observed_orcids":["https://orcid.org/0009-0005-1132-3993"]},"institutions":[{"id":"https://openalex.org/I4402554138","display_name":"Jan Biziel University Hospital No. 2 in Bydgoszcz","ror":"https://ror.org/05r81yb60","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I3019271933","https://openalex.org/I4210148386","https://openalex.org/I4402554138"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Rafa\u0142 Wojciechowski","raw_affiliation_strings":["Clinic and Department of Rheumatology and Systemic Diseases of Connective Tissue, University Hospital No. 2, Bydgoszcz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic and Department of Rheumatology and Systemic Diseases of Connective Tissue, University Hospital No. 2, Bydgoszcz, Poland","institution_ids":["https://openalex.org/I4402554138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030799484","display_name":"Katarzyna Kolossa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katarzyna Kolossa","raw_affiliation_strings":["MICS Centrum Medyczne, Bydgoszcz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MICS Centrum Medyczne, Bydgoszcz, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064075793","display_name":"Anna Dudek","orcid":"https://orcid.org/0000-0003-1461-6271","observed_orcids":["https://orcid.org/0000-0003-1461-6271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Dudek","raw_affiliation_strings":["Centrum Medyczne Amed, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centrum Medyczne Amed, Warsaw, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089712806","display_name":"Magdalena Krajewska\u2013W\u0142odarczyk","orcid":"https://orcid.org/0000-0002-7857-347X","observed_orcids":["https://orcid.org/0000-0002-7857-347X"]},"institutions":[{"id":"https://openalex.org/I47996466","display_name":"University of Warmia and Mazury in Olsztyn","ror":"https://ror.org/05s4feg49","country_code":"PL","type":"education","lineage":["https://openalex.org/I47996466"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Krajewska-W\u0142odarczyk","raw_affiliation_strings":["Clinic of Rheumatology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic of Rheumatology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland","institution_ids":["https://openalex.org/I47996466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036530922","display_name":"Pawe\u0142 Hrycaj","orcid":"https://orcid.org/0000-0003-1253-8062","observed_orcids":["https://orcid.org/0000-0003-1253-8062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pawe\u0142 Hrycaj","raw_affiliation_strings":["Department of Rheumatology, Municipal Hospital, Ko\u015bcian, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Municipal Hospital, Ko\u015bcian, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027093730","display_name":"Piotr Adrian Klimiuk","orcid":"https://orcid.org/0000-0003-3457-6203","observed_orcids":["https://orcid.org/0000-0003-3457-6203"]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Piotr Adrian Klimiuk","raw_affiliation_strings":["Department of Rheumatology and Internal Diseases, Medical University of Bialystok and Inter Clinic Piotr Adrian Klimiuk, Bia\u0142ystok, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology and Internal Diseases, Medical University of Bialystok and Inter Clinic Piotr Adrian Klimiuk, Bia\u0142ystok, Poland","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076851275","display_name":"Gerd R\u00fcdiger Burmester","orcid":"https://orcid.org/0000-0001-7518-1131","observed_orcids":["https://orcid.org/0000-0001-7518-1131"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerd R Burmester","raw_affiliation_strings":["Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0001-7518-1131","affiliations":[{"raw_affiliation_string":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110981037","display_name":"SungHyun Kim","orcid":"https://orcid.org/0000-0003-3898-0393","observed_orcids":["https://orcid.org/0000-0003-3898-0393"]},"institutions":[{"id":"https://openalex.org/I4210158021","display_name":"Celltrion (South Korea)","ror":"https://ror.org/05k84m754","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210158021"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"SungHyun Kim","raw_affiliation_strings":["Celltrion, Inc, Incheon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celltrion, Inc, Incheon, Republic of Korea","institution_ids":["https://openalex.org/I4210158021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023866431","display_name":"Yunju Bae","orcid":"https://orcid.org/0009-0002-3827-6742","observed_orcids":["https://orcid.org/0009-0002-3827-6742"]},"institutions":[{"id":"https://openalex.org/I4210158021","display_name":"Celltrion (South Korea)","ror":"https://ror.org/05k84m754","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210158021"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"YunJu Bae","raw_affiliation_strings":["Celltrion, Inc, Incheon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celltrion, Inc, Incheon, Republic of Korea","institution_ids":["https://openalex.org/I4210158021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064050444","display_name":"Go Eun Yang","orcid":"https://orcid.org/0000-0002-8689-8127","observed_orcids":["https://orcid.org/0000-0002-8689-8127"]},"institutions":[{"id":"https://openalex.org/I4210158021","display_name":"Celltrion (South Korea)","ror":"https://ror.org/05k84m754","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210158021"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"GoEun Yang","raw_affiliation_strings":["Celltrion, Inc, Incheon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celltrion, Inc, Incheon, Republic of Korea","institution_ids":["https://openalex.org/I4210158021"]}]},{"author_position":"middle","author":{"id":null,"display_name":"YooBin Jung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158021","display_name":"Celltrion (South Korea)","ror":"https://ror.org/05k84m754","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210158021"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"YooBin Jung","raw_affiliation_strings":["Celltrion, Inc, Incheon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celltrion, Inc, Incheon, Republic of Korea","institution_ids":["https://openalex.org/I4210158021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021069975","display_name":"JiWoo Hong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158021","display_name":"Celltrion (South Korea)","ror":"https://ror.org/05k84m754","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210158021"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"JiWoo Hong","raw_affiliation_strings":["Celltrion, Inc, Incheon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celltrion, Inc, Incheon, Republic of Korea","institution_ids":["https://openalex.org/I4210158021"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080646462","display_name":"Edward Clark Keystone","orcid":"https://orcid.org/0000-0001-6606-0071","observed_orcids":["https://orcid.org/0000-0001-6606-0071"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Edward Keystone","raw_affiliation_strings":["University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5090753435"],"corresponding_institution_ids":["https://openalex.org/I76134821"],"apc_list":{"value":1950,"currency":"GBP","value_usd":2391},"apc_paid":{"value":1950,"currency":"GBP","value_usd":2391},"fwci":2.0076,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.86930146,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"10","issue":"4","first_page":"e004514","last_page":"e004514"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.035100001841783524,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":0.9449999928474426},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9729999899864197},{"id":"https://openalex.org/keywords/il-6-receptor-inhibitor","display_name":"IL-6 receptor inhibitor","score":0.6970000267028809},{"id":"https://openalex.org/keywords/das28-esr","display_name":"DAS28-ESR","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7900000214576721},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.9819999933242798},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.5550000071525574},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.961600661277771},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7088494896888733},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6654232740402222},{"id":"https://openalex.org/C2778143017","wikidata":"https://www.wikidata.org/wiki/Q111208","display_name":"Erythrocyte sedimentation rate","level":2,"score":0.6285004615783691},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5703296661376953},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.560791552066803},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.43631336092948914},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4225374460220337},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41753214597702026},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.32528379559516907},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3204272389411926}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1136/rmdopen-2024-004514","doi":"https://doi.org/10.1136/rmdopen-2024-004514","is_oa":true,"landing_page_url":"https://doi.org/10.1136/rmdopen-2024-004514","pdf_url":"https://rmdopen.bmj.com/content/10/4/e004514.full.pdf","source":{"id":"https://openalex.org/S2738706341","display_name":"RMD Open","issn_l":"2056-5933","issn":["2056-5933"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11492937","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11492937","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11492937/pdf/rmdopen-10-4.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"Text"},{"id":"pmid:39424404","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39424404","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD open","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:57062166f2dd4fe39a65b97114a32a54","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/57062166f2dd4fe39a65b97114a32a54","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RMD Open, Vol 10, Iss 4 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/rmdopen-2024-004514","doi":"https://doi.org/10.1136/rmdopen-2024-004514","is_oa":true,"landing_page_url":"https://doi.org/10.1136/rmdopen-2024-004514","pdf_url":"https://rmdopen.bmj.com/content/10/4/e004514.full.pdf","source":{"id":"https://openalex.org/S2738706341","display_name":"RMD Open","issn_l":"2056-5933","issn":["2056-5933"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320318316","display_name":"Celltrion","ror":"https://ror.org/05k84m754"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403533442.pdf","grobid_xml":"https://content.openalex.org/works/W4403533442.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W180335173","https://openalex.org/W1041331430","https://openalex.org/W1608734376","https://openalex.org/W2052951012","https://openalex.org/W2054059257","https://openalex.org/W2054789510","https://openalex.org/W2054839097","https://openalex.org/W2069473482","https://openalex.org/W2096862304","https://openalex.org/W2097874407","https://openalex.org/W2118502261","https://openalex.org/W2128952811","https://openalex.org/W2132810505","https://openalex.org/W2139339400","https://openalex.org/W2142004396","https://openalex.org/W2150952126","https://openalex.org/W2151858167","https://openalex.org/W2163480494","https://openalex.org/W2230391954","https://openalex.org/W2523403681","https://openalex.org/W2619420016","https://openalex.org/W2744892122","https://openalex.org/W2895590824","https://openalex.org/W2991070104","https://openalex.org/W3001827567","https://openalex.org/W3209722108","https://openalex.org/W4221069611","https://openalex.org/W4254038388","https://openalex.org/W4292528167","https://openalex.org/W4295125684","https://openalex.org/W4307228818","https://openalex.org/W4308769923","https://openalex.org/W4313316832","https://openalex.org/W4314935920","https://openalex.org/W4319440519","https://openalex.org/W4378347895","https://openalex.org/W4389879474","https://openalex.org/W4389886027","https://openalex.org/W4390580270","https://openalex.org/W4391543457"],"related_works":["https://openalex.org/W4412362734","https://openalex.org/W2951647574","https://openalex.org/W4414601608","https://openalex.org/W4401228933","https://openalex.org/W2883406108","https://openalex.org/W2623304866","https://openalex.org/W2519049669","https://openalex.org/W2755886239","https://openalex.org/W2523403681","https://openalex.org/W4416106147"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"demonstrate":[2],"efficacy":[3,217],"equivalence":[4,109,121,190],"of":[5,128],"CT-P47":[6,29,65,67,244],"and":[7,105,150,177,206,220,238,245],"EU-approved":[8],"reference":[9],"tocilizumab":[10],"(r-TCZ)":[11],"in":[12,90,94,195,247],"patients":[13,26,50,63,168],"with":[14,140,249],"rheumatoid":[15],"arthritis":[16],"(RA).":[17],"METHODS:":[18],"This":[19],"double-blind,":[20],"phase":[21],"III":[22],"study":[23],"randomised":[24,54,170],"(1:1)":[25,55],"to":[27,46,56,61,159,228,256],"receive":[28],"or":[30,59,134],"r-TCZ":[31,52,58,246,255],"(8":[32],"mg/kg)":[33],"every":[34,71],"4":[35,72],"weeks":[36,73],"until":[37,74],"week":[38,47,75,103,106,132,144,160,198,208,229],"20":[39],"during":[40],"treatment":[41,116,183],"period":[42],"(TP)":[43],"1.":[44],"Prior":[45],"24":[48,209],"dosing,":[49],"receiving":[51,64],"were":[53,85,118,155,169,185,223],"continue":[57],"switch":[60],"CT-P47;":[62,172],"continued":[66],"(TP2,":[68],"8":[69],"mg/kg":[70],"48).":[76],"The":[77,175],"dual":[78],"primary":[79],"endpoints":[80],"(for":[81],"different":[82],"regulatory":[83],"requirements)":[84],"mean":[86],"changes":[87],"from":[88,254],"baseline":[89],"Disease":[91],"Activity":[92],"Score":[93],"28":[95],"joints":[96],"(DAS28;":[97],"erythrocyte":[98],"sedimentation":[99],"rate":[100],"(ESR))":[101],"at":[102,131,143,197,207],"12":[104,133,199],"24.":[107],"Efficacy":[108,232],"was":[110,200,210,241],"determined":[111,242],"if":[112],"CIs":[113,179],"for":[114,180],"the":[115,181,188,192],"difference":[117,194],"within":[119,187],"predefined":[120,189],"margins:":[122],"(95%":[123,202],"CI":[124,136,203,213],"-0.6,":[125,137],"0.6":[126],"(analysis":[127],"covariance":[129],"(ANCOVA))":[130],"90%":[135,178],"0.5":[138],"(ANCOVA":[139],"multiple":[141],"imputation)":[142],"24).":[145],"Additional":[146],"efficacy,":[147],"pharmacokinetic":[148],"(PK)":[149],"safety":[151,222,237],"endpoints,":[152,218],"including":[153,251],"immunogenicity,":[154],"investigated.":[156],"Findings":[157],"up":[158,227],"32":[161],"are":[162],"presented.":[163],"RESULTS:":[164],"In":[165],"TP1,":[166],"471":[167],"(234":[171],"237":[173],"r-TCZ).":[174],"95%":[176],"estimated":[182,193],"differences":[184],"contained":[186],"margins;":[191],"DAS28-ESR":[196],"-0.01":[201],"-0.26,":[204],"0.24)":[205],"-0.10":[211],"(90%":[212],"-0.30,":[214],"0.10).":[215],"Secondary":[216],"PKs":[219],"overall":[221],"comparable":[224,235],"between":[225,243],"groups":[226],"32.":[230],"CONCLUSIONS:":[231],"equivalence,":[233],"alongside":[234],"PK,":[236],"immunogenicity":[239],"profiles,":[240],"adults":[248],"RA,":[250],"after":[252],"switching":[253],"CT-P47.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-10-19T00:00:00"}